So, Brigatinib is this ALK inhibitor thing, and it’s used to treat that ALK-positive cancer in people with non-small cell lung cancer. They got this stuff in three doses: 30 mg, 90 mg, and 180 mg, all in those easy-to-swallow pills. You start with 90 mg a day for the first week, then kick it up to 180 mg every day after that.
Each bottle has 30 tablets in it. It works by blocking this ALK thing, which is super important for how that cancer grows and spreads. The idea is to zero in on that ALK protein and keep it from making those tumor cells grow out of control.
